Media Statement: Zepbound (tirzepatide) KwikPen now available at self-pay pricing at major pharmacies nationwide in addition to LillyDirect

Eli Lilly announced on April 10, 2026 that the Zepbound KwikPen is now available at self-pay prices at major retail pharmacies nationwide — not just through its own LillyDirect mail pharmacy. The expansion covers Amazon Pharmacy, Walgreens, Sam’s Club, Publix, and Kroger (which joined the program on March 13, 2026). Combined with GoodRx coverage at over 70,000 pharmacy locations, this is effectively a nationwide rollout of the savings card pricing to wherever you get your prescriptions filled. For the millions of patients without insurance coverage — or those who prefer in-person pickup or same-day access — this is the most meaningful access expansion for Zepbound since its late 2023 launch.

The pricing tiers are: $299/month for the 2.5 mg starting dose, $399/month for 5 mg, and $449/month for all maintenance doses (7.5 mg, 10 mg, 12.5 mg, 15 mg). All tiers require the free Zepbound KwikPen Self-Pay Savings Card, available to any commercially insured or uninsured patient with a valid on-label prescription — no income verification, no insurance requirement. The card is valid through December 31, 2026. Zepbound’s retail list price without the card exceeds $1,050/month. That $600–$750/month gap is not a small coupon; it’s the difference between a drug that fits a household budget and one that doesn’t.

Before this expansion, savings card pricing existed only through LillyDirect’s mail pharmacy. That worked for patients comfortable with home delivery, but it locked out anyone needing same-day access, patients without reliable mailing addresses, or people whose regular pharmacy wasn’t part of the LillyDirect network. Amazon Pharmacy covers both delivery and the retail network, so patients now have every combination of pickup and mail covered. One restriction that hasn’t changed: the savings card is unavailable to Medicare, Medicaid, VA, and TRICARE patients under federal program rules. If you’re on any of those, the Medicare GLP-1 Bridge program launching July 2026 at $245/month is the more relevant pathway to explore.

One thing worth flagging for your calendar: the savings card expires December 31, 2026. Lilly has renewed it multiple times since Zepbound launched, but there’s no guarantee of continuation. If the card lapses without a 2027 replacement, self-pay patients revert to $1,050+/month overnight. Set a reminder in October 2026 to check whether the program has been extended — and if you hear nothing, call your pharmacist in December before your January refill.

Frequently Asked Questions

How do I enroll in the Zepbound KwikPen Self-Pay Savings Card?

Go to zepbound.lilly.com/savings or ask your pharmacist to enroll you at the point of sale. You need a valid on-label Zepbound prescription, to be 18 or older, and to be a US or Puerto Rico resident. The card is free and there’s no income threshold or insurance requirement to qualify. It works at Amazon Pharmacy, Kroger, Sam’s Club, Walgreens, Publix, and LillyDirect. Medicare, Medicaid, VA, and TRICARE patients are excluded under federal program rules.

What’s the difference between the Zepbound KwikPen and single-dose vials?

The KwikPen is a prefilled auto-injector pen — dial, press, discard. Single-dose vials require a separate syringe and needle for each injection and are generally available only through LillyDirect, not retail pharmacies. Lilly sells vials at $399–$549/month for a four-vial pack through LillyDirect. The savings card expansion described here applies specifically to the KwikPen. The vials were introduced to provide an alternative supply channel during the pen shortage period; most new patients are prescribed the KwikPen.

Should I use the savings card or GoodRx for Zepbound?

Check both before you pay — it takes 90 seconds. The savings card generally wins for most doses at major chains, but GoodRx prices vary by pharmacy location and sometimes beat the card at specific stores. If you qualify for the savings card (commercially insured or self-pay, not on government programs), enroll first and then run a GoodRx lookup at your specific pharmacy. Use whichever is cheaper at the point of sale. Either way, never pay the $1,050+ list price without checking at least one discount option first.

---

Keep Reading

• Zepbound: Full Medication Profile
• Mounjaro vs Zepbound: Same Tirzepatide, Different Labels
• Wegovy vs Zepbound: Head-to-Head Comparison
• Semaglutide vs Tirzepatide: Which Wins?